BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 10722009)

  • 1. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
    O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of cervical lymph node metastases to primary sites of carcinoma of the upper aerodigestive tract: a pathological study.
    Cole I; Hughes L
    Aust N Z J Surg; 1997 Dec; 67(12):860-5. PubMed ID: 9451342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
    Koo BS; Lim YC; Lee JS; Choi EC
    Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer.
    Ross G; Shoaib T; Soutar DS; Camilleri IG; Gray HW; Bessent RG; Robertson AG; MacDonald DG
    Arch Otolaryngol Head Neck Surg; 2002 Nov; 128(11):1287-91. PubMed ID: 12431172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed topography of cervical lymph-note metastases from oral squamous cell carcinoma.
    Woolgar JA
    Int J Oral Maxillofac Surg; 1997 Feb; 26(1):3-9. PubMed ID: 9081244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in node-negative squamous cell carcinoma of the oral cavity and oropharynx.
    Burns P; Foster A; Walshe P; O'Dwyer T
    J Laryngol Otol; 2009 Apr; 123(4):439-43. PubMed ID: 18796178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified neck dissection. A study of 967 cases from 1970 to 1980.
    Byers RM
    Am J Surg; 1985 Oct; 150(4):414-21. PubMed ID: 4051103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx.
    Duvvuri U; Simental AA; D'Angelo G; Johnson JT; Ferris RL; Gooding W; Myers EN
    Laryngoscope; 2004 Dec; 114(12):2228-34. PubMed ID: 15564851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective neck dissection for N0 and N1 oral cavity and oropharyngeal cancer: are skip metastases a real danger?
    Lodder WL; Sewnaik A; den Bakker MA; Meeuwis CA; Kerrebijn JD
    Clin Otolaryngol; 2008 Oct; 33(5):450-7. PubMed ID: 18983378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
    Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
    Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma.
    Eckel HE; Volling P; Pototschnig C; Zorowka P; Thumfart W
    Laryngoscope; 1995 Jan; 105(1):53-60. PubMed ID: 7837914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.
    Pericot J; Escribà JM; Valdés A; Biosca MJ; Monner A; Castellsagué X; Galiana R; Piulachs P; Escutia E; Mari A
    J Craniomaxillofac Surg; 2000 Feb; 28(1):49-55. PubMed ID: 10851674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node localization in oral cavity and oropharynx squamous cell cancer.
    Taylor RJ; Wahl RL; Sharma PK; Bradford CR; Terrell JE; Teknos TN; Heard EM; Wolf GT; Chepeha DB
    Arch Otolaryngol Head Neck Surg; 2001 Aug; 127(8):970-4. PubMed ID: 11493208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective neck dissection in oral carcinoma: a critical review of the evidence.
    Kowalski LP; Sanabria A
    Acta Otorhinolaryngol Ital; 2007 Jun; 27(3):113-7. PubMed ID: 17883186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma.
    Lee SY; Lim YC; Song MH; Lee JS; Koo BS; Choi EC
    Oral Oncol; 2006 Nov; 42(10):1017-21. PubMed ID: 16757201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermoid carcinoma of the oral cavity and oropharynx: validity of the current AJCC staging system and new statistical tools for the prediction of subclinical neck disease.
    Ghouri AF; Zamora RL; Harvey JE; Spitznagel EL; Sessions DG
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):225-32. PubMed ID: 8464634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.
    Zbären P; Nuyens M; Caversaccio M; Stauffer E
    Am J Surg; 2006 Jun; 191(6):756-60. PubMed ID: 16720144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.